RESPIVANT

Trademark usage description

pharmaceutical preparations for human use for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical pr Read More

Classification Information

Class [005]
Pharmaceutical preparations for human use for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for human use for the treatment and prevention of inflammatory and fibrotic diseases and disorders and their symptoms, namely, primary biliary cirrhosis, allergy, secondary sclerosing cholangitis, cholangiopathy, pruritis, itching associated with chronic kidney disease requiring dialysis, itching caused by or associated with primary biliary cirrohosis, bronchiolitis obliterans syndrome, irritable bowel syndrome, functional dyspepsia, bronchopulmonary dysplasia, primary sclerosing cholangitis, Morbihan disease, asthma, vulvodynia, chronic pelvic pain syndrome (prostatitis), Parkinson's disease, Alzheimer's disease, chronic idiopathic urticaria, mastocytosis, fibrotic skin disease, kidney fibrosis, hepatic fibrosis, rheumatoid arthritis, interstitial cystitis; biological preparations for medical and therapeutic purposes for the treatment and prevention of respiratory diseases and disorders and their symptoms; biological preparations for medical and therapeutic purposes for the treatment and prevention of inflammatory and fibrotic diseases, namely, primary biliary cirrhosis, allergy, secondary sclerosing cholangitis, cholangiopathy, pruritis, itching associated with chronic kidney disease requiring dialysis, itching caused by or associated with primary biliary cirrohosis, bronchiolitis obliterans syndrome, irritable bowel syndrome, functional dyspepsia, bronchopulmonary dysplasia, primary sclerosing cholangitis, Morbihan disease, asthma, vulvodynia, chronic pelvic pain syndrome (prostatitis), Parkinson's disease, Alzheimer's disease, chronic idiopathic urticaria, mastocytosis, fibrotic skin disease, kidney fibrosis, hepatic fibrosis, rheumatoid arthritis, interstitial cystitis

Classification kind code

Class [042]
Scientific and technological services and research and design relating thereto, namely, the design and testing of new products for others; pharmaceutical and biomedical research services in the field of treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical and biomedical research services in the field of treatment and prevention of inflammatory and fibrotic diseases and disorders, namely, primary biliary cirrhosis, allergy, secondary sclerosing cholangitis, cholangiopathy, pruritis, itching associated with chronic kidney disease requiring dialysis, itching caused by or associated with primary biliary cirrohosis, bronchiolitis obliterans syndrome, irritable bowel syndrome, functional dyspepsia, bronchopulmonary dysplasia, primary sclerosing cholangitis, Morbihan disease, asthma, vulvodynia, chronic pelvic pain syndrome (prostatitis), Parkinson's disease, Alzheimer's disease, chronic idiopathic urticaria, mastocytosis, fibrotic skin disease, kidney fibrosis, hepatic fibrosis, rheumatoid arthritis, interstitial cystitis; research in the field of pharmaceutical and biologic therapeutic preparations in the field of treatment and prevention of respiratory diseases and disorders and their symptoms; research in the field of pharmaceutical and biologic therapeutic preparations in the field of treatment and prevention of inflammatory and fibrotic diseases and disorders, namely, primary biliary cirrhosis, allergy, secondary sclerosing cholangitis, cholangiopathy, pruritis, itching associated with chronic kidney disease requiring dialysis, itching caused by or associated with primary biliary cirrohosis, bronchiolitis obliterans syndrome, irritable bowel syndrome, functional dyspepsia, bronchopulmonary dysplasia, primary sclerosing cholangitis, Morbihan disease, asthma, vulvodynia, chronic pelvic pain syndrome (prostatitis), Parkinson's disease, Alzheimer's disease, chronic idiopathic urticaria, mastocytosis, fibrotic skin disease, kidney fibrosis, hepatic fibrosis, rheumatoid arthritis, interstitial cystitis; pharmaceutical research and development in the field of treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical research and development in the field of treatment and prevention of inflammatory and fibrotic diseases and disorders, namely, primary biliary cirrhosis, allergy, secondary sclerosing cholangitis, cholangiopathy, pruritis, itching associated with chronic kidney disease requiring dialysis, itching caused by or associated with primary biliary cirrohosis, bronchiolitis obliterans syndrome, irritable bowel syndrome, functional dyspepsia, bronchopulmonary dysplasia, primary sclerosing cholangitis, Morbihan disease, asthma, vulvodynia, chronic pelvic pain syndrome (prostatitis), Parkinson's disease, Alzheimer's disease, chronic idiopathic urticaria, mastocytosis, fibrotic skin disease, kidney fibrosis, hepatic fibrosis, rheumatoid arthritis, interstitial cystitis; providing scientific research information in the field of pharmaceuticals and biomedicine in the field of treatment and prevention of respiratory diseases and disorders and their symptoms; providing scientific research information in the field of pharmaceuticals and biomedicine in the field of treatment and prevention of inflammatory and fibrotic diseases and disorders, namely, primary biliary cirrhosis, allergy, secondary sclerosing cholangitis, cholangiopathy, pruritis, itching associated with chronic kidney disease requiring dialysis, itching caused by or associated with primary biliary cirrohosis, bronchiolitis obliterans syndrome, irritable bowel syndrome, functional dyspepsia, bronchopulmonary dysplasia, primary sclerosing cholangitis, Morbihan disease, asthma, vulvodynia, chronic pelvic pain syndrome (prostatitis), Parkinson's disease, Alzheimer's disease, chronic idiopathic urticaria, mastocytosis, fibrotic skin disease, kidney fibrosis, hepatic fibrosis, rheumatoid arthritis, interstitial cystitis;

Classification kind code

Class [044]
Providing health information and medical information in the field of treatment and prevention of respiratory diseases and disorders and their symptoms; providing health and medical information in the field of treatment and prevention of inflammatory and fibrotic diseases and disorders, namely, primary biliary cirrhosis, allergy, secondary sclerosing cholangitis, cholangiopathy, pruritis, itching associated with chronic kidney disease requiring dialysis, itching caused by or associated with primary biliary cirrohosis, bronchiolitis obliterans syndrome, irritable bowel syndrome, functional dyspepsia, bronchopulmonary dysplasia, primary sclerosing cholangitis, Morbihan disease, asthma, vulvodynia, chronic pelvic pain syndrome (prostatitis), Parkinson's disease, Alzheimer's disease, chronic idiopathic urticaria, mastocytosis, fibrotic skin disease, kidney fibrosis, hepatic fibrosis, rheumatoid arthritis, interstitial cystitis; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of respiratory diseases and disorders and their symptoms; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of inflammatory and fibrotic diseases and disorders, namely, primary biliary cirrhosis, allergy, secondary sclerosing cholangitis, cholangiopathy, pruritis, itching associated with chronic kidney disease requiring dialysis, itching caused by or associated with primary biliary cirrohosis, bronchiolitis obliterans syndrome, irritable bowel syndrome, functional dyspepsia, bronchopulmonary dysplasia, primary sclerosing cholangitis, Morbihan disease, asthma, vulvodynia, chronic pelvic pain syndrome (prostatitis), Parkinson's disease, Alzheimer's disease, chronic idiopathic urticaria, mastocytosis, fibrotic skin disease, kidney fibrosis, hepatic fibrosis, rheumatoid arthritis, interstitial cystitis;

Classification kind code

Mark Details

Serial Number

1900858

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 4^th Dec 2019	Advertised
Submitted for opposition 26 on 14^th Nov 2019	Approved
Submitted for opposition 27 on 14^th Nov 2019	Approval Notice Sent
Submitted for opposition 12 on 15^th May 2019	Extension of Time
Submitted for opposition 80 on 26^th Feb 2019	Change of Title Registered
Submitted for opposition 22 on 31^st Oct 2018	Search Recorded
Submitted for opposition 20 on 31^st Oct 2018	Examiner's First Report
Submitted for opposition 31 on 30^th May 2018	Formalized
Submitted for opposition 30 on 25^th May 2018	Filed
Submitted for opposition 1 on 25^th May 2018	Created